Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH

Enrolling by invitation · Phase 2

Conditions studied: Pulmonary Hypertension of Newborn, Diaphragm Defect

In brief

The purpose of this study is to evaluate the effect of a parenteral emulsion containing n-3 long-chain polyunsaturated fatty acids (LC-PUFA) in fish oil on clinical outcomes, markers of inflammation and oxidative stress, and pain in neonates with persistent pulmonary hypertension of the newborn (PPHN) compared with those who receive an emulsion containing soy oil and medium-chain triglycerides (MCT) without n-3 LC-PUFA.

Key facts

Study ID
NCT04031508
Run by
Coordinación de Investigación en Salud, Mexico
People needed
40
Starts
2019-08-12
Expected to finish
2026-12-01
Last updated by the study team
2026-03-18

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.